Trial Profile
Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and a Interruption Versus Continuation of Double Antiplatelet Therapy, One Year After Stenting.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Aspirin
- Indications Coronary artery disease; Stent thrombosis
- Focus Therapeutic Use
- Acronyms ARCTIC; ARCTIC-GENE
- 29 Aug 2018 Results of a pooled analysis from ARCTIC and ANTARCTIC trials, presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology
- 03 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
- 06 Sep 2012 Planned end date changed from 1 Jul 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.